Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 1, 2026, Enhabit, Inc. (EHAB) has a Wall Street consensus price target of $13.53, based on estimates from 11 covering analysts. With the stock currently trading at $13.61, this represents a potential downside of -0.6%. The company has a market capitalization of $686M.
Analyst price targets range from a low of $12.00 to a high of $14.00, representing a 15% spread in expectations. The median target of $13.80 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 3 analysts rating the stock as a Buy or Strong Buy,7 rating it Hold, and 1 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, EHAB trades at a trailing P/E of -4.4x and forward P/E of 22.5x. Analysts expect EPS to grow +359.8% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how EHAB stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonWall Street's consensus price target for EHAB is $13.53, -0.6% from its current price of $13.61. The below-market target from 11 analysts suggests limited near-term appreciation.
EHAB has a consensus rating of "Hold" based on 11 Wall Street analysts. The rating breakdown is mixed, with 7 Hold ratings making up the largest segment. The consensus 12-month price target of $13.53 implies -0.6% downside from current levels.
EHAB trades at a forward P/E of 22.4959x, representing a moderate valuation. With analysts targeting $13.53 (-0.6% implied move), the stock appears close to fair value.
The most bullish Wall Street analyst has a price target of $14 for EHAB, while the most conservative target is $12. The consensus of $13.53 represents the median expectation. These targets typically reflect 12-month expectations.
EHAB is moderately covered, with 11 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 7 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month EHAB stock forecast based on 11 Wall Street analysts shows a consensus price target of $13.53, with estimates ranging from $12 (bear case) to $14 (bull case). The median consensus rating is "Hold".
EHAB trades at a forward P/E ratio of 22.5x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on EHAB, with 1 Sell ratings and a price target of $13.53 (-0.6% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
EHAB analyst price targets range from $12 to $14, a 15% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $13.53 consensus represents the middle ground.